Sign In
Buy PRNB
$100.05
+0 (+0%)
At Close: May 27, 2022
The Daily Biotech Pulse: ASH Meeting Wraps, Fast Track Designation For Equillium, Pfizer To Buy $3M In ContraFect Shares
12:56pm, Tuesday, 10'th Dec 2019
The following are top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Dec. 9.) Acceleron Pharma Inc (NASDAQ: XLRN ) Aimmune Therapeut
Principia Presents Consistent Positive Data of PRN1008 for Immune Thrombocytopenia in Ongoing Phase 1/2 Trial
03:00pm, Saturday, 07'th Dec 2019
Principia Biopharma Inc. (PRNB), a late-stage biopharmaceutical company focused on developing novel therapies for immune mediated diseases, today announced consistent positive data from an ongoing Pha
Principia to Present at the Stifel Healthcare Conference 2019
01:01pm, Wednesday, 13'th Nov 2019
Principia Biopharma Inc. (PRNB), a late-stage biopharmaceutical company focused on developing novel therapies for immune mediated diseases, today announced that management will participate in the Stif
Principia Biopharma Inc. (PRNB) Reports Q3 Loss, Lags Revenue Estimates
11:25pm, Tuesday, 05'th Nov 2019
Principia Biopharma Inc. (PRNB) delivered earnings and revenue surprises of -9.41% and -100.00%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for th
Principia Biopharma Reports Third Quarter Financial Results
09:01pm, Tuesday, 05'th Nov 2019
SOUTH SAN FRANCISCO, Calif., Nov. 05, 2019 -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company focused on developing novel therapies for immune.
Is Principia Biopharma Inc. (PRNB) A Good Stock To Buy?
09:47pm, Monday, 28'th Oct 2019
The Insider Monkey team has completed processing the quarterly 13F filings for the June quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge fun
These 24 Bay Area drug and diagnostics companies quietly raised nearly $3B this year
02:23pm, Friday, 18'th Oct 2019
While initial public offerings get most of the splash, public companies also are raking in cash with follow-on offerings. How long will the Wall Street spigot stay open?
The Daily Biotech Pulse: Akebia Sues CMS, Roche Raises Guidance Yet Again, Titan Medical Entangled In Credit Crunch
11:06am, Wednesday, 16'th Oct 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 15) Celgene Corporation (NASDAQ: CELG ) Eagle Pharmace
Principia Announces Pricing of Public Offering of Common Stock
02:24am, Wednesday, 16'th Oct 2019
Principia Biopharma Inc. (PRNB), a late-stage biopharmaceutical company focused on developing novel therapies for immune mediated diseases, today announced the pricing of its underwritten public offer
Principia Announces Proposed Public Offering of Common Stock
08:02pm, Tuesday, 15'th Oct 2019
Principia Biopharma Inc. (PRNB), a late-stage biopharmaceutical company focused on developing novel therapies for immune mediated diseases, today announced that it has commenced an underwritten public
